a-aminocaproic acid

L-Norleucine ((S)-Norleucine) is an isomer of leucine, specifically affects protein synthesis in skeletal muscle, and has antivirus activity.

6-Aminocaproic acid-(S,R,S)-AHPC-Me serves as a ligand and linker for the E3 ubiquitin ligase in PROTACs, facilitating the synthesis of PVD-06 for research in oncology.

6-Aminocaproic acid hydrochloride, a monoamino carboxylic acid derivative, is a potent, orally active antifibrinolytic agent that inhibits plasmin and plasminogen. It competitively binds to lysine residues on plasminogen, preventing clot lysis by inhibiting plasmin formation and reducing fibrinolysis. This compound is utilized in researching bleeding disorders.

6-Aminocaproic acid-D6 is the deuterated form of 6-Aminocaproic acid (T0881) (EACA), a monoamino carboxylic acid. This compound acts as an effective and orally active inhibitor of plasmin and plasminogen. It serves as a potent antifibrinolytic agent by competitively binding to lysine residues on plasminogen, preventing clot dissolution, inhibiting plasmin formation, and reducing fibrinolysis. Additionally, 6-Aminocaproic acid (T0881) is utilized in the study of hemorrhagic disorders.

6-Aminocaproic Acid-D6 (Standard) is a reference standard of 6-Aminocaproic Acid-D6 intended for quantitative analysis, quality control, and related biochemical research applications. 6-Aminocaproic acid-d6 is the deuterated form of 6-Aminocaproic acid (EACA), a monoamino carboxylic acid. This compound acts as an effective and orally active inhibitor of plasmin and plasminogen. It serves as a potent antifibrinolytic agent by competitively binding to lysine residues on plasminogen, preventing clot dissolution, inhibiting plasmin formation, and reducing fibrinolysis. Additionally, 6-Aminocaproic acid is utilized in the study of hemorrhagic disorders.

Pip6a is an arginine-rich cell-penetrating peptide that facilitates the transport of drugs across plasma and endosomal membranes. It consists of a hydrophobic core flanked by arginine-rich domains containing β-alanine and aminocaproic acid spacers. When Pip6a is combined with morpholino phosphorodiamidate oligomer (PMO), it significantly enhances the delivery of antisense oligonucleotides (ASO) to the striated muscle of myotonic dystrophy type 1 (DM1) mice.

Aminocaproic nitrilotriacetic acid is a biochemical reagent that can be used as a biomaterial for life science related research and as a sulfonylation reagent for organic synthesis and drug discovery.